Abstract
In the late 1980s, Jon Wolff of the University of Wisconsin and Phil Felgner here at Vical were screening cationic lipids for their ability to encapsulate and deliver purified plasmid DNA into mouse tissues. They discovered that direct injection of lipid-DNA complexes into muscle resulted in measurable protein expression. A belated control experiment without lipid led to the serendipitous discovery that “naked” plasmid DNA was taken up and expressed in muscle to a greater extent than DNA-lipid complexes (1). This key observation led to the demonstration that i.m. injection in mice of a standard 50 μg of plasmid DNA encoding a reporter gene becomes readily expressed exclusively in myofiber cells at 180 pg of gene product per muscle (2). More recently, plasmid DNA expression vectors were improved such that an average of 300 ng of gene product could be produced from single intramuscular (i.m.) injections of plasmid DNA, and up to 40 μg of gene product could be produced after multiple injections (3 and J. Hartikka, unpublished observations).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Felgner, P. L. (1997) Nonviral strategies for gene therapy. Sci. Am. 276, 102–106.
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., and Felgner, P. L. (1990) Direct gene transfer into mouse muscle in vivo. Science 247, 1465–1468.
Hartikka, J., Sawdey, M., Cornefert-Jensen, F., Margalith, M., Barnhart, K., Nolasco, M., et al. (1996) An improved plasmid DNA Expression vector for direct injection into skeletal muscle. Hum. Gen. Ther. 7, 1205–1217.
Felgner, P. L. and Rhodes, G. (1991) Gene therapeutics. Nature 349, 351–352.
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein [see comments]. Science 259, 1745–1749.
Ulmer, J. B., Sadoff, J. C., and Liu, M. A. (1996) DNA vaccines. Curr. Opin. Immunol. 8, 531–536.
Danko, I., Fritz, J. D., Jiao, S., Hogan, K., Latendresse, J. S., and Wolff, J. A. (1994) Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther. 1, 114–121.
Vitadello, M., Schiaffino, M. V., Picard, A., Scarpa, M., and Schiaffino, S. (1994). Gene transfer in regenerating muscle. Hum. Gene Ther. 5, 8–11.
Wells, D. J. (1993) Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle. FEBS Lett. 332, 179–182.
Davis H.L., Whalen, R. G., Demeneix, B. A. (1993) Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151–159.
Coney, L., Wang, B., Ugen, K. E., Boyer, J., McCallus, D., Srikantan, V., et al. (1994) Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine 12, 1545–1550.
Mumper, R. J., Duguid, J. G., Anwer, K., Barron, M. K., Nitta, H., and Rolland, A. P. (1996) Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res. 13, 701–709.
Zhu, N., Liggitt, D., Liu, Y., and Debs, R. (1993) Systemic gene expression after intravenous DNA delivery into adult mice. Science 261, 209–211.
Debs, R., Pian, M., Gaensler, K., Clements, J., Friend, D. S., and Dobbs, L. (1992) Prolonged transgene expression in rodent lung cells. Am. J. Respir. Cell Mol. Biol. 7, 406–413.
Thierry, A. R., Lunardi-Iskandar, Y., Bryant, J. L., Rabinovich, P., Gallo, R. C., and Mahan, L. C. (1995) Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc. Natl. Acad. Sci. USA 92, 9742–9746.
Gregoriadis, G., Saffie, R., and de Souza, J. B. (1997) Liposome-mediated DNA vaccination. FEBS Lett. 402, 107–110.
Levy, M. Y., Barron, L. G., Meyer, K. B., and Szoka, F. C., Jr. (1996) Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 3, 201–211.
Peet, N. M., McKeating, J. A., Ramos, B., Klonisch, T., De Souza, J. B., Delves, P.J., and Lund, T. (1997) Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120. Clin. Exp. Immunol. 109, 226–232.
Winegar, R.A., Monforte, J.A., Suing, K.D., O’Loughlin, K.G., Rudd, C.J., and Macgregor, J.T. (1996) Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridization. Hum. Gene Ther. 7, 2185–2194.
Doh, S. G., Vahlsing, H. L., Hartikka, J., Liang, X., and Manthorpe, M. (1997) Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA. Gene Ther. 4, 648–663.
Davis, H. L., Demeneix, B. A., Quantin, B., Coulombe, J., and Whalen, R. G. (1993) Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4, 733–740.
Wheeler, C. J., Felgner, P. L., Tsai, Y. J., Marshall, J., Sukhu, L., Doh, S. G., et al. (1996) A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA 93, 11,454–11,459.
Nabel, G. J., Nabel, E. G., Yang, Z. Y., Fox, B. A., Plautz, G. E., Gao, X., et al. (1993) Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11,307–11,311.
Stephan, D. J., Yang, Z. Y., San, H., Simari, R. D., Wheeler, C. J., Felgner, P. L., et al. (1996) A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum. Gene Ther. 7, 1803–1812.
Pardoll, D. M. and Beckerleg, A. M. (1995) Exposing the immunology of naked DNA vaccines. Immunity 3, 165–169.
Corr, M., Lee, D. J., Carson, D. A., Tighe H. (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555–1560.
Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C. M. (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93, 8578–8583.
Ulmer, J. B., Deck, R. R., Dewitt, C. M., Donnelly, J. I., and Liu, M. A. (1996) Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89, 59–67.
Fu, T. M., Ulmer, J.B., Caufield, M. J., Deck, R. R., Friedman, A., Wang, S., et al. (1997) Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3, 362–371.
Lew, D., Parker, S. E., Latimer, T., Abai, A. M., Kuwahara-Rundell, A., Doh, S. G., et al. (1995) Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum. Gen. Ther. 6, 553–564.
Su, D. and Van Rooijen, N. (1989) The role of macrophages in the immuno-adjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen. Immunology 66, 466–470.
Verma, J. N., Wassef, N. M., Wirtz, R. A., Atkinson, C. T., Aikawa, M., Loomis, L. D., and Alving, C. R. (1991) Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen. Biochim. Biophys. Acta 1066, 229–238.
Hsu, M. J. and Juliano, R. L. (1982) Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta 720, 411–419.
Stacey, K. I., Sweet, M. J., and Hume, D. A. (1996) Macrophages ingest and are activated by bacterial DNA. Immunology 157, 2116–2122.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A laboratory manual, 2nd ed. Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY.
Horn, N. A., Meek, J. A., Budahazi, G., and Marquet, M. (1995) Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum. Gen. Ther. 6, 565–573.
Manthorpe, M., Hartikka, J., Vahlsing, H.L. and Sawdey, M. (1999) Quantification of plasmid DNA expression in vivo, in Gene Quantification (Ferre, F., ed.) Burkhauser, Cambridge, MA. In press.
Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., and Dwarki, V. (1993) Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gen. Ther. 4, 419–431.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Norman, J., Hartikka, J., Strauch, P., Manthorpe, M. (2000). Adjuvants for Plasmid DNA Vaccines. In: Lowrie, D.B., Whalen, R.G. (eds) DNA Vaccines. Methods in Molecular Medicine™, vol 29. Humana Press. https://doi.org/10.1385/1-59259-688-6:185
Download citation
DOI: https://doi.org/10.1385/1-59259-688-6:185
Publisher Name: Humana Press
Print ISBN: 978-0-89603-580-5
Online ISBN: 978-1-59259-688-1
eBook Packages: Springer Protocols